| Ytd | -22.38% | |
| 1y | 7.89% |
| Open | 33.01 | Prev Close | 33.08 | Low | 32.53 | High | 35.22 | Mkt Cap | 1.60B |
| Vol | 1.04M | Avg Vol | 750.99K | EPS | 0.84 | P/E | 41.86 | Forward P/E | 16.82 |
| Beta | 0.97 | Short Ratio | 4.16 | Inst. Own | 108.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 39.72 | 200-d Avg | 40.73 | 1yr Est | 57.86 |
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Wells Fargo 21st Annual Healthcare Co
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
The disposal comprised 6,753 shares representing a total transaction value of ~$250,000. The transac
Bank of America Corp DE raised its holdings in Omnicell, Inc. (NASDAQ: OMCL) by 31.3% in the first q
OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and del
Omnicell's 20.1% monthly slide reflects booking uncertainty, margin pressure and refresh-cycle risks
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowe
On July 31, 2026, Omnicell Inc (OMCL) shares fell 4.7% today, bringing the current price to $35.37.
Omnicell highlights Titan XT and OmniSphere momentum, and raises profit outlook, while customer appr
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lower
Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers th
Dimensional Fund Advisors LP raised its holdings in Omnicell, Inc. (NASDAQ: OMCL) by 6.0% in the fir
FORT WORTH, Texas--(BUSINESS WIRE)--EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — De
Omnicell NASDAQ: OMCL reported second-quarter 2026 revenue at the high end of its prior outlook and
Omnicell, Inc. (OMCL) Q2 2026 Earnings Call Transcript
Omnicell (OMCL) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Est
Omnicell (NASDAQ:OMCL) is looking for Q3 Adj EPS of $0.35-$0.43 vs $0.47 analyst estimate. sees sale
Omnicell (NASDAQ:OMCL) raises FY2026 Adj EPS guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 analy
Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.94 per share which beat the analyst consens
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Second Quarter 2026 Financial Results.
OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring reve
Omnicell is advancing its autonomous pharmacy vision and expanding SaaS offerings, but tariffs and f
Shares of Omnicell OMCL have rallied 52.6% over the past year, significantly outperforming the indus
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leading healthcare tec
FORT WORTH, Texas--(BUSINESS WIRE)--Nnamdi Njoku appointed President of Omnicell leading global oper
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Him
Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and raises th
US stocks down, NASDAQ falls over 1% on Tuesday. Dow up 0.20%, NASDAQ down 1.24%, S&P 500 down 0
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimate
Omnicell (NASDAQ:OMCL) raises FY2026 Adj EPS guidance from $1.65-$1.85 to $1.80-$2.00 vs $1.75 analy
Omnicell (NASDAQ:OMCL) is looking for Q2 Adj EPS of $0.40-$48.00 vs $0.41 analyst estimate. sees sal
Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.55 per share which beat the analyst consens
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and raise